Business description
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen.
Management board & Supervisory board
| CEO |
| Bill Anderson |
| Management board |
| Wolfgang Nickl, Heike Prinz, Rodrigo Santos, Stefan Oelrich, Julio Triana |
| Supervisory board |
| Prof. Dr. Norbert Winkeljohann, Heike Hausfeld, Dr. Paul Achleitner, Horst Baier, André van Broich, Ertharin Cousin, Yasmin Fahimi, Dr. Barbara Gansewendt, Colleen A. Goggins, Francesco Grioli, Kimberly Mathisen, Andrea Sacher, Claudia Schade, Lori Schechter, Dr. Nancy Simonian, Jeffrey Ubben, Alberto Weisser, Michael Westmeier, Marianne Maehl |
Company data
| Name: |
Bayer AG |
| Address: |
Kaiser-Wilhelm-Allee 1,D-51368 Leverkusen |
| Phone: |
+49-214-30-1 |
| Fax: |
+49-214-30-81013 |
| E-mail: |
info@bayer.com
|
| Internet: |
www.bayer.de |
| Industry: |
Commodities |
| Sector: |
Chemicals |
| Sub sector: |
- |
| End of financial year: |
12/31 |
| Free Float: |
68.44% |
| IPO date: |
10/1/1953 |
Investor relations
| Name: |
Oliver Maier |
| IR phone: |
+49-214-30-65742 |
| IR Fax: |
+49-214-30-9665742 |
| IR e-mail: |
oliver.maier@bayer.com
|